FDA
approval
· 2026-02-25
FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for tafluprost ophthalmic from Prasco Laboratories, enabling the marketing of a generic tafluprost ophthalmic solution. …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TAFLUPROST OPHTHALMIC (TAFLUPROST)